Sign In to View Organizational & Contract Pricing.
Select a Size
About This Item
NACRES:
NA.41
UNSPSC Code:
12352203
Conjugate:
unconjugated
Clone:
polyclonal
Application:
WB
Citations:
7
biological source
rabbit
conjugate
unconjugated
antibody form
affinity isolated antibody
antibody product type
primary antibodies
clone
polyclonal
form
buffered aqueous solution
mol wt
antigen ~43 kDa
species reactivity
human
enhanced validation
recombinant expression
Learn more about Antibody Enhanced Validation
technique(s)
western blot: 1-2 μg/mL using extracts of Raji cells
UniProt accession no.
shipped in
dry ice
storage temp.
−20°C
target post-translational modification
unmodified
Gene Information
human ... LPXN(9404)
General description
Leupaxin gene is mapped to human chromosome 11q12.1. Leupaxin belongs to the paxillin protein family It is mainly expressed in macrophages, lymphoid tissues and hematopoietic cells. Leupaxin comprises two types of protein interaction domains, LIM domain and leucine−aspartate (LD) motifs. LIM domains mediate localization to focal contacts. LD motifs facilitates focal adhesion kinase (FAK) and vinculin binding, resulting in the localization of focal adhesion kinase (FAK) to focal adhesions. The C-terminal LIM domains in leupaxin share 70% amino acid identity with paxillin. The N-terminal region of leupaxin comprises three short stretches of 13 amino acids that share 70− 90% similarity with paxillin LD motifs.
Application
Anti-Leupaxin antibody produced in rabbit has been used in immunoblotting and proximity ligation assay.
Biochem/physiol Actions
Anti-Leupaxin (N-terminal) specifically recognizes human leupaxin.
Leupaxin in association with a second focal adhesion kinase (FAK) family member, PYK2, acts a cell type-specific signaling complex regulator in leukocytes. It acts as a tyrosine kinase substrate in lymphoid cells and thus, may function in and be regulated by tyrosine kinase activity. Leupaxin facilitates adhesion and invasion of prostate carcinoma cells. It can form a complex with PYK2 and PTP-PEST in various cells such as monocytes and osteoclasts and in prostate cancer cells. In osteoclasts, leupaxin acts as a key nucleating component of the osteoclast podosomal signaling complex in the adhesion zone.
Physical form
Solution in 0.01 M phosphate buffered saline, pH 7.4, containing 15 mM sodium azide.
Preparation Note
Store at –20 °C. For continuous use, the product may be stored at 2–8 °C for up to one month. For extended storage, freeze at –20 °C in working aliquots. Repeated freezing and thawing, or storage in “frost-free” freezers, is not recommended. If slight turbidity occurs upon prolonged storage, clarify the solution by centrifugation before use. Working dilutions should be discarded if not used within 12 hours.
Disclaimer
Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.
Not finding the right product?
Try our Product Selector Tool.
Storage Class
10 - Combustible liquids
flash_point_f
Not applicable
flash_point_c
Not applicable
Regulatory Information
新产品
This item has
Choose from one of the most recent versions:
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Leupaxin stimulates adhesion and migration of prostate cancer cells through modulation of the phosphorylation status of the actin-binding protein caldesmon
Dierks S, et al.
Oncotarget, 6(15), 13591-13591 (2015)
Sascha Dierks et al.
Oncotarget, 6(15), 13591-13606 (2015-06-17)
The focal adhesion protein leupaxin (LPXN) is overexpressed in a subset of prostate cancers (PCa) and is involved in the progression of PCa. In the present study, we analyzed the LPXN-mediated adhesive and cytoskeletal changes during PCa progression. We identified
Leupaxin is a critical adaptor protein in the adhesion zone of the osteoclast
Gupta A, et al.
Journal of Bone and Mineral Research, 18(4), 669-685 (2003)
Structural basis for the interaction between Pyk2-FAT domain and leupaxin LD repeats
Vanarotti MS, et al.
Biochemistry, 55(9), 1332-1345 (2016)
Leupaxin promotes bladder cancer proliferation, metastasis, and angiogenesis through the PI3K/AKT pathway
Hou T, et al.
Cellular Physiology and Biochemistry, 47(6), 2250-2260 (2018)
Related Content
Instructions
Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.
Contact Technical Service